{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:39:19Z","timestamp":1793320759191,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001734","name":"K\u00f8benhavns Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005404","name":"Arbejdstilsynet","doi-asserted-by":"publisher","award":["20070033239\/4"],"award-info":[{"award-number":["20070033239\/4"]}],"id":[{"id":"10.13039\/501100005404","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.expneurol.2020.113396","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T11:12:03Z","timestamp":1593688323000},"page":"113396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Compromised IGF signaling causes caspase-6 activation in Huntington disease"],"prefix":"10.1016","volume":"332","author":[{"given":"Niels Henning","family":"Skotte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Pouladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar E.","family":"Ehrnhoefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe Marie Borch","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels Tolstrup","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2561-7683","authenticated-orcid":false,"given":"Anne","family":"N\u00f8rrem\u00f8lle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2020.113396_bb0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1100\/tsw.2006.22","article-title":"Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain","volume":"6","author":"Aberg","year":"2006","journal-title":"Sci. World J."},{"key":"10.1016\/j.expneurol.2020.113396_bb0010","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/hmg\/ddv023","article-title":"A huntingtin-based peptide inhibitor of caspase-6 provides protection from mutant huntingtin-induced motor and behavioral deficits","volume":"24","author":"Aharony","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2020.113396_bb0015","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1097\/CCM.0000000000001314","article-title":"Predictors of circulating insulin-like growth Factor-1 and insulin-like growth factor-binding Protein-3 in critical illness","volume":"43","author":"Ahasic","year":"2015","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.expneurol.2020.113396_bb0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fendo.2018.00117","article-title":"IGF-binding proteins: why do they exist and why are there so many?","volume":"9","author":"Allard","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.expneurol.2020.113396_bb0025","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.cdd.4400733","article-title":"Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis","volume":"7","author":"Allsopp","year":"2000","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2020.113396_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/hmg\/3.1.65","article-title":"A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive testing","volume":"3","author":"Andrew","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2020.113396_bb0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1742-7843.2009.00472.x","article-title":"Effects of insulin-like growth factor-1 on rotenone-induced apoptosis in human lymphocyte cells","volume":"106","author":"Avila-Gomez","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.expneurol.2020.113396_bb0040","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000334276.09729.0e","article-title":"Weight loss in Huntington disease increases with higher CAG repeat number","volume":"71","author":"Aziz","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2020.113396_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0092-8674(05)80085-6","article-title":"Role of insulin-like growth factors in embryonic and postnatal growth","volume":"75","author":"Baker","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2020.113396_bb0050","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.expneurol.2020.113396_bb0055","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0896-6273(95)90216-3","article-title":"Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons","volume":"14","author":"Beck","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2020.113396_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112441","article-title":"Neurotrophic and neuroregenerative effects of GH\/IGF1","volume":"18","author":"Bianchi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2020.113396_bb0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-3-319-60189-2_6","article-title":"Manganese and the insulin-IGF signaling network in Huntington\u2019s disease and other neurodegenerative disorders","volume":"18","author":"Bryan","year":"2017","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.expneurol.2020.113396_bb0070","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington\u2019s disease","volume":"8","author":"van der Burg","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2020.113396_bb0075","doi-asserted-by":"crossref","first-page":"15371","DOI":"10.1074\/jbc.M112.351213","article-title":"Inhibitory mechanism of caspase-6 phosphorylation revealed by crystal structures, molecular dynamics simulations, and biochemical assays","volume":"287","author":"Cao","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2020.113396_bb0080","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1474-4422(15)00177-5","article-title":"Treating the whole body in Huntington\u2019s disease","volume":"14","author":"Carroll","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2020.113396_bb0085","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington\u2019s disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113396_bb0090","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/sj.cdd.4401065","article-title":"Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: absolute requirement for removal of caspase-6 prodomain","volume":"9","author":"Cowling","year":"2002","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2020.113396_bb0095","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.expneurol.2020.113396_bb0100","doi-asserted-by":"crossref","first-page":"R393","DOI":"10.1186\/ar1201","article-title":"Pharmacological disruption of insulin-like growth factor 1 binding to IGF-binding proteins restores anabolic responses in human osteoarthritic chondrocytes","volume":"6","author":"De Ceuninck","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.expneurol.2020.113396_bb0105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.expneurol.2011.06.016","article-title":"IGF-1 protects against diabetic features in an in vivo model of Huntington\u2019s disease","volume":"231","author":"Duarte","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113396_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027680","article-title":"A quantitative method for the specific assessment of caspase-6 activity in cell culture","volume":"6","author":"Ehrnhoefer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2020.113396_bb0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/1073858410390378","article-title":"Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease","volume":"17","author":"Ehrnhoefer","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1016\/j.expneurol.2020.113396_bb0120","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/hmg\/ddt458","article-title":"p53 increases caspase-6 expression and activation in muscle tissue expressing mutant huntingtin","volume":"23","author":"Ehrnhoefer","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2020.113396_bb0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40478-018-0518-0","article-title":"Preventing mutant huntingtin proteolysis and intermittent fasting promote autophagy in models of Huntington disease","volume":"6","author":"Ehrnhoefer","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.expneurol.2020.113396_bb0130","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.chembiol.2019.07.001","article-title":"Activation of caspase-6 is promoted by a mutant huntingtin fragment and blocked by an allosteric inhibitor compound","volume":"26","author":"Ehrnhoefer","year":"2019","journal-title":"Cell. Chem. Biol."},{"key":"10.1016\/j.expneurol.2020.113396_bb0135","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1242\/dmm.006775","article-title":"Unbound (bioavailable) IGF1 enhances somatic growth","volume":"4","author":"Elis","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.expneurol.2020.113396_bb0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrn3209","article-title":"The many faces of insulin-like peptide signalling in the brain","volume":"13","author":"Fernandez","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113396_bb0145","article-title":"Insulin-like growth factor 2 (IGF2) protects against Huntington\u2019s disease through the extracellular disposal of protein aggregates","author":"Garc\u00eda-Huerta","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.expneurol.2020.113396_bb0150","first-page":"699","article-title":"IGF-I\/IGFBP system: metabolism outline and physical exercise","volume":"35","author":"Gatti","year":"2012","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.expneurol.2020.113396_bb0155","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.expneurol.2007.12.026","article-title":"The metabolic profile of early Huntington\u2019s disease\u2013a combined human and transgenic mouse study","volume":"210","author":"Goodman","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113396_bb0160","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin","volume":"125","author":"Graham","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2020.113396_bb0165","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1523\/JNEUROSCI.2071-10.2010","article-title":"Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo","volume":"30","author":"Graham","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113396_bb0170","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11357-010-9182-4","article-title":"Connecting serum IGF-1, body size, and age in the domestic dog","volume":"33","author":"Greer","year":"2011","journal-title":"Age (Dordr.)"},{"key":"10.1016\/j.expneurol.2020.113396_bb0175","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.bone.2005.11.021","article-title":"Postnatal growth and bone mass in mice with IGF-I haploinsufficiency","volume":"38","author":"He","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.expneurol.2020.113396_bb0180","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35037710","article-title":"The biochemistry of apoptosis","volume":"407","author":"Hengartner","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2020.113396_bb0185","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.celrep.2017.10.097","article-title":"Spatiotemporal proteomic profiling of Huntington\u2019s disease inclusions reveals widespread loss of protein function","volume":"21","author":"Hosp","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2020.113396_bb0190","doi-asserted-by":"crossref","first-page":"13557","DOI":"10.1002\/jcp.28034","article-title":"ROS- and HIF1alpha-dependent IGFBP3 upregulation blocks IGF1 survival signaling and thereby mediates high-glucose-induced cardiomyocyte apoptosis","volume":"234","author":"Huang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.expneurol.2020.113396_bb0195","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","article-title":"The IGF-1\/Akt pathway is neuroprotective in Huntington\u2019s disease and involves huntingtin phosphorylation by Akt","volume":"2","author":"Humbert","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.expneurol.2020.113396_bb0200","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/nen.0b013e3180302078","article-title":"Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains","volume":"66","author":"Itoh","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113396_bb0205","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/er.2008-0028","article-title":"Unraveling insulin-like growth factor binding protein-3 actions in human disease","volume":"30","author":"Jogie-Brahim","year":"2009","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.expneurol.2020.113396_bb0210","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2337\/db14-0568","article-title":"Insulin action in brain regulates systemic metabolism and brain function","volume":"63","author":"Kleinridders","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.expneurol.2020.113396_bb0215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1179\/174313208X331572","article-title":"Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington\u2019s disease knock-in striatal cell line","volume":"31","author":"Kong","year":"2009","journal-title":"Neurol. Res."},{"key":"10.1016\/j.expneurol.2020.113396_bb0220","doi-asserted-by":"crossref","first-page":"23426","DOI":"10.1074\/jbc.274.33.23426","article-title":"Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer\u2019s disease","volume":"274","author":"LeBlanc","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2020.113396_bb0225","doi-asserted-by":"crossref","DOI":"10.1177\/1178626419842176","article-title":"The role of insulin-like growth factors and insulin-like growth factor-binding proteins in the nervous system","volume":"12","author":"Lewitt","year":"2019","journal-title":"Biochem. Insights"},{"key":"10.1016\/j.expneurol.2020.113396_bb0230","first-page":"59","article-title":"Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)","volume":"75","author":"Liu","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2020.113396_bb0235","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s12035-013-8585-5","article-title":"IGF-1 intranasal administration rescues Huntington\u2019s disease phenotypes in YAC128 mice","volume":"49","author":"Lopes","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2020.113396_bb0240","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","article-title":"Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2020.113396_bb0245","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/11.17.1927","article-title":"Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington\u2019s disease mouse models reveal context-independent effects","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2020.113396_bb0250","doi-asserted-by":"crossref","first-page":"9492","DOI":"10.1073\/pnas.132241599","article-title":"Apoptotic threshold is lowered by p53 transactivation of caspase-6","volume":"99","author":"MacLachlan","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2020.113396_bb0255","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell."},{"key":"10.1016\/j.expneurol.2020.113396_bb0260","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1093\/hmg\/ddu027","article-title":"Identification of a post-translationally myristoylated autophagy-inducing domain released by caspase cleavage of huntingtin","volume":"23","author":"Martin","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2020.113396_bb0265","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1096\/fj.201701510RRR","article-title":"Identification of a novel caspase cleavage site in huntingtin that regulates mutant huntingtin clearance","volume":"33","author":"Martin","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2020.113396_bb0270","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/mds.26006","article-title":"Animal models of Huntington\u2019s disease for translation to the clinic: best practices","volume":"29","author":"Menalled","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2020.113396_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000647","article-title":"Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression","volume":"2","author":"Mochel","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2020.113396_bb0280","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/ejhg.2010.72","article-title":"Dietary anaplerotic therapy improves peripheral tissue energy metabolism in patients with Huntington\u2019s disease","volume":"18","author":"Mochel","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.expneurol.2020.113396_bb0285","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1210\/endo.142.5.8165","article-title":"Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice","volume":"142","author":"Modric","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.expneurol.2020.113396_bb0290","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12035-014-8735-4","article-title":"Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington\u2019s disease human lymphoblasts","volume":"51","author":"Naia","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2020.113396_bb0295","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.npep.2016.01.009","article-title":"Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin","volume":"58","author":"Naia","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.expneurol.2020.113396_bb0300","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.neuron.2010.08.007","article-title":"Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS","volume":"67","author":"Nishijima","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2020.113396_bb0305","doi-asserted-by":"crossref","first-page":"19287","DOI":"10.1074\/jbc.M114.623561","article-title":"Integration-independent transgenic Huntington disease fragment mouse models reveal distinct phenotypes and life span in vivo","volume":"290","author":"O\u2019Brien","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2020.113396_bb0310","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000054584","article-title":"Interactions of IGF-1 with the blood-brain barrier in vivo and in situ","volume":"72","author":"Pan","year":"2000","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.expneurol.2020.113396_bb0315","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/01.WCB.0000098520.11962.37","article-title":"Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats","volume":"24","author":"Pike","year":"2004","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2020.113396_bb0320","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00415-018-8940-6","article-title":"Multiple clinical features of Huntington\u2019s disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration","volume":"266","author":"Podvin","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2020.113396_bb0325","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/eje.0.1510451","article-title":"Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington\u2019s disease","volume":"151","author":"Popovic","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.expneurol.2020.113396_bb0330","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/brain\/awp006","article-title":"Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin","volume":"132","author":"Pouladi","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2020.113396_bb0335","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/hmg\/ddq026","article-title":"Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression","volume":"19","author":"Pouladi","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2020.113396_bb0340","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1749-6632.1993.tb26240.x","article-title":"Inactivation of the IGF-I gene in mice results in perinatal lethality","volume":"692","author":"Powell-Braxton","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2020.113396_bb0345","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2014.06.023","article-title":"Insulin and IGF-1 improve mitochondrial function in a PI-3K\/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington\u2019s disease knock-in striatal cells","volume":"74","author":"Ribeiro","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.expneurol.2020.113396_bb0350","doi-asserted-by":"crossref","first-page":"9723","DOI":"10.1523\/JNEUROSCI.3044-08.2008","article-title":"Dysregulation of gene expression in primary neuron models of Huntington\u2019s disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry","volume":"28","author":"Runne","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113396_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004962","article-title":"Neuroendocrine disturbances in Huntington\u2019s disease","volume":"4","author":"Saleh","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2020.113396_bb0360","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/jnnp.2010.208553","article-title":"Growth hormone response to arginine test differentiates between two subgroups of Huntington\u2019s disease patients","volume":"82","author":"Salvatore","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2020.113396_bb0365","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/11.17.1953","article-title":"Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses","volume":"11","author":"Sipione","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2020.113396_bb0370","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/cdd.2016.139","article-title":"Palmitoylation of caspase-6 by HIP14 regulates its activation","volume":"24","author":"Skotte","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2020.113396_bb0375","doi-asserted-by":"crossref","first-page":"7320","DOI":"10.1074\/jbc.M008363200","article-title":"Executioner caspase-3, \u22126, and \u22127 perform distinct, non-redundant roles during the demolition phase of apoptosis","volume":"276","author":"Slee","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2020.113396_bb0380","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/hmg\/ddi192","article-title":"Gene expression in Huntington\u2019s disease skeletal muscle: a potential biomarker","volume":"14","author":"Strand","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2020.113396_bb0385","doi-asserted-by":"crossref","first-page":"7067","DOI":"10.1038\/sj.onc.1207963","article-title":"Regulation of caspase-6 and FLIP by the AMPK family member ARK5","volume":"23","author":"Suzuki","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.expneurol.2020.113396_bb0390","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1128\/MCB.24.8.3526-3535.2004","article-title":"ARK5 is a tumor invasion-associated factor downstream of Akt signaling","volume":"24","author":"Suzuki","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.expneurol.2020.113396_bb0395","doi-asserted-by":"crossref","first-page":"13915","DOI":"10.1074\/jbc.M511354200","article-title":"NDR2 acts as the upstream kinase of ARK5 during insulin-like growth factor-1 signaling","volume":"281","author":"Suzuki","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2020.113396_bb0400","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/EJE-10-0703","article-title":"Circulating levels of IGF1 are associated with muscle strength in middle-aged- and oldest-old women","volume":"164","author":"Taekema","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.expneurol.2020.113396_bb0405","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ecl.2012.04.016","article-title":"Insulin-like growth factor-1 and central neurodegenerative diseases","volume":"41","author":"Torres Aleman","year":"2012","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.expneurol.2020.113396_bb0410","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","article-title":"Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells","volume":"9","author":"Trettel","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2020.113396_bb0415","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1523\/JNEUROSCI.1305-11.2012","article-title":"Transgenic mouse model expressing the caspase 6 fragment of mutant huntingtin","volume":"32","author":"Waldron-Roby","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113396_bb0420","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1177585","article-title":"Small-molecule activators of a proenzyme","volume":"326","author":"Wolan","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2020.113396_bb0425","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainresbull.2007.12.007","article-title":"Increased thirst and drinking in Huntington\u2019s disease and the R6\/2 mouse","volume":"76","author":"Wood","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2020.113396_bb0430","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1093\/hmg\/ddn281","article-title":"Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons","volume":"17","author":"Zala","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2020.113396_bb0435","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/jnr.1059","article-title":"TNF-alpha stimulates caspase-3 activation and apoptotic cell death in primary septo-hippocampal cultures","volume":"64","author":"Zhao","year":"2001","journal-title":"J. Neurosci. Res."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488620302272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488620302272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:51:34Z","timestamp":1762149094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488620302272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":87,"alternative-id":["S0014488620302272"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2020.113396","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compromised IGF signaling causes caspase-6 activation in Huntington disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2020.113396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113396"}}